Representing Dr. Vince Clinical Research, Dr. Toni Grant, Director of Pharmacokinetics, presented “Optimizing Pharmacokinetics in Clinical Development” at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2025 Annual Meeting in Washington, D.C. In this session, she discussed strategies for using pharmacokinetic (PK) tools to guide dosing decisions, optimize clinical development and minimize the burden on patients and study participants.
Key Learning Objectives:
- Understanding the role of pharmacokinetics in drug development.
- Explore the use of PK to guide dose selection and enhance clinical trial efficiency.
- Identify strategies for optimizing study design to reduce patient/subject burden.
- Learn how PK modeling can be used to inform study design and streamline clinical
development.
